Less than two years after buying Chinese biotech Gracell for its cell therapy platform, AstraZeneca has reported encouraging clinical results with the lead CAR-T from the deal, GC012F (now AZD0120), ...
How college and high school athletes can monetize their NIL Greg Daugherty has worked 25+ years as an editor and writer for major publications and websites. He is also the author of two books. David ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback